PLX Protalix Biotherapeutics, Inc.
Fundamentals / CIK 0001006281 / USDProtalix Biotherapeutics, Inc. reported $84.69M in revenue and net income of $20.55M for the trailing twelve months ended September 30, 2026 (up 22.8% year over year), with a 71.2% gross margin and a 29.8% operating margin.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PLX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$84.69M +22.8% YoY
-
Operating Income TTM$25.21M 29.8% margin
-
Net Income TTM$20.55M 24.3% net margin
-
Diluted EPS TTM$0.25 Split-adjusted
-
Free Cash Flow TTM$15.06M 17.8% FCF margin
-
Cash & ST Investments Sep 30, 2026$22.04M Total debt: $9.14M
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $52.74M | $53.40M | $65.49M | $47.64M | $38.35M | $62.90M | $54.69M | $34.24M | $21.08M | $9.20M |
| Cost of Revenue | $26.99M | $24.32M | $22.98M | $19.59M | $16.35M | $10.87M | $10.89M | $9.30M | $15.23M | $8.40M |
| Gross Profit | $25.75M | $29.08M | $42.51M | $28.05M | $22.00M | $52.02M | $43.80M | $24.94M | $4.01M | $801K |
| Research & Development | $19.57M | $12.97M | $17.09M | $29.35M | $29.73M | $38.17M | $44.62M | $33.33M | $32.17M | $30.41M |
| Selling, General & Admin | $11.68M | $12.19M | $14.96M | $11.71M | $12.73M | $11.15M | $9.90M | $10.92M | $11.53M | $9.36M |
| Operating Income | -$5.50M | $3.92M | $10.46M | -$13.01M | -$20.46M | $2.71M | -$10.72M | -$19.31M | -$34.52M | -$33.16M |
| EBITDA | -$4.04M | $5.22M | $11.65M | -$11.93M | -$19.34M | $4.01M | -$9.10M | -$17.64M | -$32.60M | -$31.18M |
| Income Before Tax | -$5.61M | $4.15M | $8.57M | -$14.40M | -$27.58M | -$6.52M | -- | -- | -- | -- |
| Income Tax Expense | $996K | $1.22M | $254K | $530K | -- | -- | -- | -- | -- | -- |
| Net Income | -$6.60M | $2.93M | $8.31M | -$14.93M | -$27.58M | -$6.52M | -$18.28M | -$26.46M | -$83.44M | -$29.36M |
| Basic EPS | -$0.08 | $0.04 | $0.12 | -$0.31 | -$0.62 | -$0.22 | -$1.23 | -$1.80 | -$6.37 | -$2.90 |
| Diluted EPS | -$0.08 | $0.04 | $0.09 | -$0.31 | -$0.62 | -$0.22 | -$1.23 | -$1.80 | -$6.37 | -$2.90 |
| Basic Shares Outstanding | 78.5M | 72.5M | 67.5M | 48.5M | 44.1M | 29.1M | 14.8M | 14.7M | 13.1M | 10.1M |
| Diluted Shares Outstanding | 78.5M | 81.1M | 82.4M | 48.5M | 44.1M | 29.1M | 14.8M | 14.7M | 13.1M | 10.1M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $21.93M | $19.90M | $33.75M | $9.12M | $17.85M | $15.66M | $10.11M | $18.22M |
| Cost of Revenue | $7.88M | $7.76M | $4.13M | $4.62M | $8.32M | $5.87M | $8.18M | $3.89M |
| Gross Profit | $14.05M | $12.13M | $29.62M | $4.50M | $9.53M | $9.79M | $1.93M | $14.33M |
| Research & Development | $6.92M | $4.35M | $5.43M | $5.63M | $4.47M | $5.99M | $3.48M | $4.12M |
| Selling, General & Admin | $3.08M | $3.11M | $3.05M | $3.53M | $2.93M | $2.62M | $2.60M | $3.00M |
| Operating Income | $4.05M | $4.67M | $21.15M | -$4.66M | $2.13M | $1.17M | -$4.14M | $7.21M |
| EBITDA | $4.47M | $5.08M | $21.55M | -$4.27M | $2.50M | $1.53M | -$3.80M | $7.54M |
| Income Before Tax | $4.62M | $4.86M | $21.14M | -$4.78M | $2.24M | $661K | -$3.73M | $7.32M |
| Income Tax Expense | $661K | $1.08M | $2.82M | $728K | -$116K | $497K | -$113K | $822K |
| Net Income | $3.96M | $3.78M | $18.32M | -$5.50M | $2.35M | $164K | -$3.62M | $6.49M |
| Basic EPS | $0.05 | $0.05 | $0.23 | -- | $0.03 | $0.00 | -$0.05 | -- |
| Diluted EPS | $0.05 | $0.05 | $0.22 | -- | $0.03 | $0.00 | -$0.05 | -- |
| Basic Shares Outstanding | 80.5M | 80.0M | 79.8M | -- | 79.3M | 78.7M | 76.6M | -- |
| Diluted Shares Outstanding | 83.6M | 82.6M | 83.0M | -- | 80.8M | 81.3M | 76.6M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $14.68M | $19.76M | $23.63M | $17.11M | $38.98M | $18.27M | $17.79M | $37.81M | $51.16M | $63.28M |
| Cash & Short-Term Investments | $14.68M | $19.76M | $23.63M | $17.11M | $38.98M | $18.27M | $17.79M | $37.81M | $51.16M | $63.28M |
| Accounts Receivable, Net | $8.84M | $2.91M | $5.27M | $4.59M | $3.44M | $2.00M | $4.70M | $4.73M | $1.72M | $693K |
| Inventory | $25.73M | $21.24M | $19.05M | $16.80M | $17.95M | $13.08M | $8.15M | $8.57M | $7.83M | $5.25M |
| Other Current Assets | $1.13M | $1.10M | $1.05M | $1.31M | $1.28M | $2.10M | $1.83M | $1.88M | $1.93M | $2.65M |
| Total Current Assets | $66.67M | $60.08M | $69.93M | $44.88M | $61.67M | $55.72M | $32.48M | $52.98M | $62.65M | $71.87M |
| Property, Plant & Equipment, Net | $4.88M | $4.59M | $4.97M | $4.55M | $4.96M | $4.84M | $5.27M | $6.39M | $7.68M | $8.70M |
| Total Non-Current Assets | $15.67M | $13.34M | $14.50M | $10.91M | $12.00M | $12.21M | $12.91M | $8.15M | $9.56M | $10.38M |
| Total Assets | $82.35M | $73.42M | $84.43M | $55.79M | $73.67M | $67.93M | $45.39M | $61.13M | $72.21M | $82.25M |
| Accounts Payable | $5.26M | $4.53M | $19.55M | $12.27M | $16.43M | $13.93M | $11.90M | $10.27M | $9.31M | $7.50M |
| Deferred Revenue (Current) | -- | -- | $0 | $13.18M | $8.55M | $5.39M | $16.34M | $9.87M | -- | $837K |
| Total Current Liabilities | $26.52M | $25.62M | $45.53M | $32.43M | $33.18M | $86.47M | $40.17M | $25.35M | $22.75M | $66.21M |
| Deferred Revenue (Non-Current) | -- | -- | -- | $0 | $11.79M | $1.72M | $16.98M | $33.03M | $25.02M | -- |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | $51K | $509K | $5.29M | $5.05M | $4.30M |
| Total Non-Current Liabilities | $7.60M | $4.58M | $5.33M | $34.00M | $46.52M | $8.50M | $75.54M | $88.66M | $78.92M | $25.99M |
| Total Liabilities | $34.12M | $30.21M | $50.87M | $66.43M | $79.70M | $94.97M | $115.7M | $114.0M | $101.7M | $92.20M |
| Total Debt (incl. Leases) | $8.32M | $5.53M | $6.03M | $5.29M | $5.58M | $5.89M | $5.70M | -- | -- | -- |
| Common Stock | $80K | $76K | $73K | $54K | $46K | $35K | $15K | $15K | $144K | $124K |
| Retained Earnings | -$385.0M | -$378.4M | -$381.5M | -$389.9M | -$374.9M | -$347.4M | -$340.8M | -$322.6M | -$296.1M | -$212.7M |
| Total Stockholders' Equity | $48.23M | $43.21M | $33.57M | -$10.64M | -$6.04M | -$27.04M | -$70.32M | -$52.88M | -$29.46M | -$9.96M |
| Total Equity | $48.23M | $43.21M | $33.57M | -$10.64M | -$6.04M | -$27.04M | -$70.32M | -$52.88M | -$29.46M | -$9.96M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $22.04M | $27.42M | $41.00M | $14.68M | $13.65M | $17.89M | $19.46M | $19.76M |
| Cash & Short-Term Investments | $22.04M | $27.42M | $41.00M | $14.68M | $13.65M | $17.89M | $19.46M | $19.76M |
| Accounts Receivable, Net | $13.91M | $16.50M | $2.94M | $8.84M | $14.43M | $9.44M | $4.67M | $2.91M |
| Inventory | $34.30M | $32.29M | $30.47M | $25.73M | $21.25M | $21.13M | $19.51M | $21.24M |
| Other Current Assets | $1.40M | $2.05M | $1.15M | $1.13M | $1.45M | $1.51M | $1.59M | $1.10M |
| Total Current Assets | $98.87M | $92.22M | $86.36M | $66.67M | $66.50M | $65.48M | $60.51M | $60.08M |
| Property, Plant & Equipment, Net | $5.77M | $5.47M | $5.15M | $4.88M | $4.72M | $4.75M | $4.72M | $4.59M |
| Total Non-Current Assets | $19.37M | $18.12M | $15.98M | $15.67M | $15.76M | $13.00M | $13.38M | $13.34M |
| Total Assets | $118.2M | $110.3M | $102.3M | $82.35M | $82.26M | $78.49M | $73.89M | $73.42M |
| Accounts Payable | $4.78M | $6.51M | $4.29M | $5.26M | $5.38M | $6.69M | $4.12M | $4.53M |
| Total Current Liabilities | $30.23M | $31.39M | $27.39M | $26.52M | $21.95M | $24.09M | $24.32M | $25.62M |
| Total Non-Current Liabilities | $7.46M | $7.54M | $7.72M | $7.60M | $7.41M | $4.49M | $4.36M | $4.58M |
| Total Liabilities | $37.69M | $38.93M | $35.11M | $34.12M | $29.36M | $28.58M | $28.68M | $30.21M |
| Total Debt (incl. Leases) | $9.14M | $9.21M | $8.48M | $8.32M | $8.18M | $5.35M | $5.24M | $5.53M |
| Common Stock | -- | -- | -- | $80K | -- | -- | -- | $76K |
| Retained Earnings | -- | -- | -- | -$385.0M | -- | -- | -- | -$378.4M |
| Total Stockholders' Equity | $80.55M | $71.40M | $67.23M | $48.23M | $52.91M | $49.90M | $45.21M | $43.21M |
| Total Equity | $80.55M | $71.40M | $67.23M | $48.23M | $52.91M | $49.90M | $45.21M | $43.21M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$6.60M | $2.93M | $8.31M | -$14.93M | -$27.58M | -$6.52M | -$18.28M | -$26.46M | -$83.44M | -$29.36M |
| Depreciation & Amortization | $1.47M | $1.30M | $1.19M | $1.09M | $1.12M | $1.30M | $1.62M | $1.67M | $1.92M | $1.98M |
| Stock-Based Compensation | $2.30M | $3.25M | $3.45M | $2.08M | $2.38M | $3.13M | $835K | $514K | $337K | $988K |
| Change in Receivables | -$5.89M | $2.32M | -$428K | -$1.19M | -$1.03M | $2.09M | $188K | -$3.10M | $25K | -$1.13M |
| Change in Inventory | -$4.49M | -$2.20M | -$2.24M | $1.15M | -$4.87M | -$4.93M | $414K | -$736K | -$2.59M | $522K |
| Operating Cash Flow | -$11.99M | $8.67M | -$1.32M | -$25.00M | -$10.29M | -$26.11M | -$19.36M | -$7.74M | -$9.99M | -$32.10M |
| Capital Expenditure | -$1.64M | -$1.28M | -$1.15M | -$628K | -$1.46M | -$655K | -$627K | -$686K | -$971K | -$849K |
| Free Cash Flow | -$13.63M | $7.39M | -$2.47M | -$25.63M | -$11.74M | -$26.76M | -$19.98M | -$8.43M | -$10.96M | -$32.95M |
| Investing Cash Flow | -$2.37M | $4.22M | -$16.71M | -$5.04M | $18.92M | -$19.95M | -$883K | -$591K | -$1.12M | -$967K |
| Common Stock Issued | $6.81M | $3.63M | $23.95M | $8.24M | $8.57M | $4.87M | -- | -- | -- | -- |
| Financing Cash Flow | $9.33M | -$16.79M | $24.67M | $8.24M | $12.08M | $46.47M | $0 | -$4.75M | -$1.42M | $19.70M |
| Net Change in Cash | -$5.08M | -$3.87M | $6.52M | -$21.87M | $20.72M | $473K | -$20.02M | -$13.36M | -$12.12M | -$13.09M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $3.96M | $3.78M | $18.32M | -$5.50M | $2.35M | $164K | -$3.62M | $6.49M |
| Depreciation & Amortization | $421K | $406K | $404K | $387K | $372K | $360K | $346K | $334K |
| Stock-Based Compensation | $601K | $398K | $532K | $732K | $598K | $427K | $540K | $654K |
| Change in Receivables | $3.26M | -$15.03M | $6.41M | $5.88M | -$4.85M | -$4.64M | -$2.27M | -$752K |
| Change in Inventory | -$2.00M | -$1.82M | -$4.75M | -$4.47M | -$124K | -$1.62M | $1.74M | -$4.04M |
| Operating Cash Flow | $3.90M | -$10.40M | $22.02M | $2.03M | -$3.73M | -$5.23M | -$5.06M | $3.99M |
| Capital Expenditure | -$737K | -$593K | -$761K | -$403K | -$498K | -$431K | -$306K | -$425K |
| Free Cash Flow | $3.17M | -$10.99M | $21.26M | $1.63M | -$4.23M | -$5.66M | -$5.36M | $3.57M |
| Investing Cash Flow | -$13.81M | -$3.63M | $4.22M | -$1.11M | -$504K | -$438K | -$312K | -$15.32M |
| Common Stock Issued | -- | -- | -- | $0 | $0 | $3.95M | $2.86M | -- |
| Financing Cash Flow | $4.58M | $0 | $150K | $146K | $0 | $4.10M | $5.08M | -- |
| Net Change in Cash | -$5.38M | -$13.58M | $26.32M | $1.03M | -$4.25M | -$1.56M | -$302K | -$7.65M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 48.8% | 54.5% | 64.9% | 58.9% | 57.4% | 82.7% | 80.1% | 72.8% | 19.0% | 8.7% |
| Operating Margin | -10.4% | 7.3% | 16.0% | -27.3% | -53.4% | 4.3% | -19.6% | -56.4% | -163.8% | -360.5% |
| Net Profit Margin | -12.5% | 5.5% | 12.7% | -31.3% | -71.9% | -10.4% | -33.4% | -77.3% | -395.9% | -319.2% |
| Return on Equity (ROE) | -13.7% | 6.8% | 24.8% | -- | -- | -- | -- | -- | -- | -- |
| Return on Assets (ROA) | -8.0% | 4.0% | 9.8% | -26.8% | -37.4% | -9.6% | -40.3% | -43.3% | -115.5% | -35.7% |
| Current Ratio | 2.51x | 2.34x | 1.54x | 1.38x | 1.86x | 0.64x | 0.81x | 2.09x | 2.75x | 1.09x |
| Quick Ratio | 1.54x | 1.52x | 1.12x | 0.87x | 1.32x | 0.49x | 0.61x | 1.75x | 2.41x | 1.01x |
| Debt to Equity | 0.17x | 0.13x | 0.18x | -- | -- | -- | -- | -- | -- | -- |
| Revenue Growth (YoY) | -1.2% | -18.5% | +37.5% | +24.2% | -39.0% | +15.0% | +59.7% | +62.4% | +129.1% | +110.8% |
| Gross Profit Growth (YoY) | -11.4% | -31.6% | +51.6% | +27.5% | -57.7% | +18.8% | +75.6% | +521.7% | +400.7% | -78.0% |
| Operating Income Growth (YoY) | -240.4% | -62.6% | -- | -- | -855.1% | -- | -- | -- | -- | -- |
| Net Income Growth (YoY) | -325.2% | -64.7% | -- | -- | -- | -- | -- | -- | -- | -150.6% |
| EPS Growth (YoY) | -300.0% | -66.7% | -- | -- | -- | -- | -- | -- | -- | -147.5% |
| Operating Cash Flow Growth (YoY) | -238.3% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -284.4% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 5Y Revenue / Share Growth | -68.9% | -80.0% | -58.3% | -38.9% | -4.2% | +369.4% | +871.9% | -- | -58.1% | -8.4% |
| 10Y Revenue / Share Growth | +46.1% | +94.1% | -- | -74.4% | -12.3% | +163.0% | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -- | -- | -- | -103.7% | -- | -- | -- | -- |
| 10Y Net Income / Share Growth | -101.4% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 71.2% | 69.2% | 70.0% | 48.8% | 57.5% | 57.5% | 50.0% | 54.5% |
| Operating Margin | 29.8% | 28.9% | 25.9% | -10.4% | 10.3% | 13.3% | 7.7% | 7.3% |
| Net Profit Margin | 24.3% | 23.5% | 20.1% | -12.5% | 8.7% | 10.1% | 6.5% | 5.5% |
| Return on Equity (ROE) | 25.5% | 26.5% | 22.8% | -13.7% | 10.2% | 12.6% | 8.6% | 6.8% |
| Return on Assets (ROA) | 17.4% | 17.2% | 15.0% | -8.0% | 6.6% | 8.0% | 5.3% | 4.0% |
| Current Ratio | 3.27x | 2.94x | 3.15x | 2.51x | 3.03x | 2.72x | 2.49x | 2.34x |
| Quick Ratio | 2.14x | 1.91x | 2.04x | 1.54x | 2.06x | 1.84x | 1.69x | 1.52x |
| Debt to Equity | 0.11x | 0.13x | 0.13x | 0.17x | 0.15x | 0.11x | 0.12x | 0.13x |
| Revenue Growth (YoY) | +22.8% | +27.1% | +233.7% | -49.9% | -0.6% | +16.2% | +169.8% | +73.7% |
| Gross Profit Growth (YoY) | +47.5% | +24.0% | +1432.5% | -68.6% | -0.6% | +143.6% | +68.7% | +779.3% |
| Operating Income Growth (YoY) | +89.9% | +298.6% | -- | -164.6% | -46.6% | -- | -- | -- |
| Net Income Growth (YoY) | +68.2% | +2203.0% | -- | -184.8% | -27.2% | -- | -- | -- |
| EPS Growth (YoY) | +66.7% | -- | -- | -- | -25.0% | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -49.1% | -190.9% | -- | -220.8% | +11.0% |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -54.4% | -205.3% | -- | -249.4% | +6.6% |